0001600132-20-000062.txt : 20200609 0001600132-20-000062.hdr.sgml : 20200609 20200609160152 ACCESSION NUMBER: 0001600132-20-000062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200605 FILED AS OF DATE: 20200609 DATE AS OF CHANGE: 20200609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wang Theodore T CENTRAL INDEX KEY: 0001694061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 20951808 MAIL ADDRESS: STREET 1: C/O PUISSANCE CAPITAL MANAGEMENT LP STREET 2: 950 THIRD AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_159173289350800.xml FORM 4 X0306 4 2020-06-05 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001694061 Wang Theodore T C/O PUISSANCE CAPITAL MANAGEMENT LP 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 10022 1 0 1 0 Common Stock 2020-06-05 4 P 0 4986 12.724 A 58313 D Common Stock 2020-06-08 4 P 0 2600 12.867 A 60913 D /s/ Theodore T. Wang 2020-06-09